You have 9 free searches left this month | for more free features.

chidamide

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Safety and Efficacy Trial in Suzhou (Chidamide)

Recruiting
  • Safety and Efficacy
  • Chidamide
  • Suzhou, Jiangsu, China
    First Affiliated Hospital,Soochow University
Nov 30, 2021

Non-hodgkin's Lymphoma Trial in Beijing (Chiauranib, Chidamide)

Completed
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 7, 2022

Acute Myeloid Leukemia Trial in Nanjing (Chidamide, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Apr 23, 2022

Breast Cancer Trial in Shanghai (Chidamide, Abemaciclib, Fulvestrant)

Recruiting
  • Breast Cancer
  • Chidamide
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 31, 2022

Metastatic Colorectal Cancer Trial in New Taipei City (chidamide, celecoxib)

Recruiting
  • Metastatic Colorectal Cancer
  • New Taipei City, Taiwan
    Taipei Medical University Shuang Ho Hospital
Mar 4, 2022

Thrombocytopenia Trial (Chidamide, HD-DXM)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Jun 6, 2022

Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

Recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Advanced Solid Tumors
  • Chidamide
  • +2 more
  • Beijing, Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Apr 8, 2022

HIV-1 Infection Trial in Kaohsiung City, Taiwan (UB-421, chidamide)

Recruiting
  • HIV-1 Infection
  • UB-421
  • chidamide
  • Kaohsiung City, Taiwan, Taiwan
    Kaohsiung Veterans General Hospital
May 12, 2022

Advanced Breast Cancer Trial in Shenyang (Chidamide, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Shenyang, Liaoning, China
    Liangning Tumor Hospital &Institute
Sep 8, 2021

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Mar 6, 2022

Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)

Not yet recruiting
  • Triple-negative Breast Cancer
  • chidamide
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2022

Peripheral T-Cell Lymphoma Trial in Zhengzhou (Parsaclisib, Chidamide)

Not yet recruiting
  • Peripheral T-Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Dec 26, 2021

Neuroendocrine Tumors, Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma Trial in Xiamen, Harbin (Chidamide, Sintilimab)

Recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Xiamen, Fujian, China
  • +1 more
Nov 22, 2021

Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Beijing, Xiamen, Harbin (Chidamide, Etoposide + Cisplatin/Carboplatin)

Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Chidamide
  • Etoposide + Cisplatin/Carboplatin
  • Beijing, Beijing, China
  • +2 more
Nov 2, 2021

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL) Trial in Guangzhou (Chidamide)

Recruiting
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
  • Chidamide
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021

Peripheral T-cell Lymphoma Trial in Beijing (Sintilimab, Chidamide, Azacidine)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Beijing, Beijing, China
    Beijing
Mar 5, 2021

Angioimmunoblastic T-cell Lymphoma Trial in Guangzhou (Sintilimab, Chidamide)

Not yet recruiting
  • Angioimmunoblastic T-cell Lymphoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 2, 2021

Non Small Cell Lung Cancer Trial in China (Chidamide, Envafolimab)

Recruiting
  • Non Small Cell Lung Cancer
  • Hefei, Anhui, China
  • +11 more
Jan 17, 2022

Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

Recruiting
  • Non Hodgkin's Lymphoma
  • Chidamide
  • +2 more
  • Beijing, Beijing, China
  • +12 more
Jun 9, 2022

Breast Cancer Trial in China (Chidamide, exemestane, )

Completed
  • Breast Cancer
  • Chidamide
  • +2 more
  • Hefei, Anhui, China
  • +21 more
Jan 10, 2022

Advanced Microsatellite Stable Colorectal Cancer, Metastatic Microsatellite-stable Colorectal Cancer Trial (Sintilimab,

Not yet recruiting
  • Advanced Microsatellite Stable Colorectal Cancer
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Feb 3, 2021

Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Chidamide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 11, 2020

Safety and Efficacy Trial in Guangzhou (Sintilimab, Chidamide, Azacitidine)

Not yet recruiting
  • Safety and Efficacy
  • Guangzhou, Guangdong, China
    Department of Medical Oncology,Sun Yat-sen University Cancer Cen
Aug 16, 2021

Hodgkin Lymphoma Trial in Beijing (Chidamide, Camrelizumab, Decitabine)

Recruiting
  • Hodgkin Lymphoma
  • Chidamide
  • +2 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Aug 12, 2020

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden Trial in Beijing (Chidamide, Decitabine, Chidamide and

Recruiting
  • Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
  • Chidamide
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Dec 3, 2020